PACS Valuation
| PACS Stock | 39.51 1.12 2.92% |
At this time, the entity appears to be overvalued. PACS Group owns a latest Real Value of USD30.67 per share. The recent price of the entity is USD39.51. Our model determines the value of PACS Group from evaluating the entity fundamentals such as operating margin of 0.0007 %, and Shares Outstanding of 155.18 M as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting PACS's valuation include:
Price Book 6.9004 | Enterprise Value | Enterprise Value Ebitda 26.7463 | Price Sales 1.1593 | Forward PE 18.4502 |
Overvalued
Today
Please note that PACS's price fluctuation is somewhat reliable at this time. Calculation of the real value of PACS Group is based on 3 months time horizon. Increasing PACS's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PACS stock is determined by what a typical buyer is willing to pay for full or partial control of PACS Group. Since PACS is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PACS Stock. However, PACS's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 39.51 | Real 30.67 | Target 34.67 | Hype 38.68 | Naive 42.65 |
The intrinsic value of PACS's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence PACS's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of PACS Group helps investors to forecast how PACS stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PACS more accurately as focusing exclusively on PACS's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use PACS's intrinsic value based on its ongoing forecasts of PACS's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against PACS's closest peers.
PACS Cash |
|
PACS Total Value Analysis
PACS Group is at this time forecasted to have valuation of 9.12 B with market capitalization of 2.24 B, debt of 3.09 B, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the PACS fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.12 B | 2.24 B | 3.09 B |
PACS Investor Information
About 72.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.23. PACS Group had not issued any dividends in recent years. Based on the key indicators related to PACS's liquidity, profitability, solvency, and operating efficiency, PACS Group may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.0329 | 0.0346 |
|
| |||||
| Total Cash From Operating Activities | 443.6 M | 422.4 M |
|
| |||||
| Operating Income | 122.7 M | 110.8 M |
|
|
PACS Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of PACS implies not a very effective usage of assets in January.PACS Ownership Allocation
PACS Group secures a total of 155.18 Million outstanding shares. PACS Group owns majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 72.28 % of PACS Group outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Also note that around one million five hundred five thousand two hundred twenty-two invesors are currently shorting PACS expressing very little confidence in its future performance.PACS Profitability Analysis
The company reported the previous year's revenue of 4.09 B. Net Income was 55.76 M with profit before overhead, payroll, taxes, and interest of 519.14 M.About PACS Valuation
The stock valuation mechanism determines PACS's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of PACS Group based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of PACS. We calculate exposure to PACS's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PACS's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 792.6 M | 513.8 M | |
| Pretax Profit Margin | 0.03 | 0.03 | |
| Operating Profit Margin | 0.03 | 0.03 | |
| Net Profit Margin | 0.02 | 0.01 | |
| Gross Profit Margin | 0.17 | 0.14 |
PACS Quarterly Retained Earnings |
|
PACS Growth Indicators
Investing in growth stocks can be very risky. If the company such as PACS does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 148.6 M | |
| Forward Price Earnings | 18.4502 |
PACS Current Valuation Indicators
PACS's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final PACS's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as PACS, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use PACS's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes PACS's worth.Additional Tools for PACS Stock Analysis
When running PACS's price analysis, check to measure PACS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PACS is operating at the current time. Most of PACS's value examination focuses on studying past and present price action to predict the probability of PACS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PACS's price. Additionally, you may evaluate how the addition of PACS to your portfolios can decrease your overall portfolio volatility.